1Tepler I, Elias L, Smith JW, et al. A randomized placebo-controlled trial of recombinsnt human interliukin-11 in canear patients with severe thrombocytopenia due to chemotherapy[J]. Blood, 1996, 87(9): 3607-3614.
2Isaaes C, Robert NJ, Bailey FA, et al. Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin[J]. J Clin Oncol, 1997, 15(11): 3368-3377.
3Perez EA, Lembersky B, Kaywin P, et al. Intravenous(IV) granisetron vs ondansetron in the prevention of cyclophosphamide-doxorubicin-induced emesis in breast cancer patients: a double blind crossover study[J]. Proc Am Soc Clin Oncol, 1996, 15: 543.
4Perez EA, Hesketh P, Sandbach J, et al. Comparison of single dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetngenic chemotherapy: a multicenter, double-blind, randimized parallel study[J]. J Clin Oncol, 1998, 16(2): 754-760.
5Navari R, Gandara D,Hesketh P,et al. Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin induced emesis[J]. J Clin Oncol, 1995, 13(5): 1242-1248.
6Gralla RJ, Navari RM, Hesketh PJ, et al. Single-dose oral granisetron, has equivalent antiernetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based ehernotherapy[J]. J Clin Oncol, 1998, 16(4): 1568-1573.
7Anonymous. Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy[J]. N Engl J Med, 2000, 342(21): 1554-1559.
8Crawford J, Ozer H, Stoller R, et al. Reduction by granuloeyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer (r-metHuC- CSF) [J]. N Engl J Med, 1991,325(3) : 164-170.
9Maher D, Green M, Bishop J, et al. Randomized, placebo controlled trial of filgrastim (r-metHuG-CSF) in patients with febrile neutropenia (FN)following chemotherapy(CT) [J]. Proc Am Soc Clin Oncol, 1993, 12: 434.
10Trillet Lenoir V, Green J, Manegold C, et al. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy[J]. Eur J Cancer, 1993, 29A(3): 319-324.
